CONTEXT: Clinical studies about detailed spectrum of aspergillosis in treated tuberculosis (TB) patients are lacking. Hence, a study was undertaken at the Institute of Respiratory Disease, Jaipur, Rajasthan, India. Treated patients of pulmonary TB having any symptom such as hemoptysis, cough with expectoration, weight loss, and whose chest X-ray showed residual cavitation were enrolled for the study.
Introduction
A spergillus is a ubiquitous saprophytic mold which includes 200 species. [1, 2] A concerning trend in the epidemiology of pulmonary fungal infection is the increasing incidence of patients in which traditional risk factors such as neutropenia are lacking. Aspergillus causes a variety of pulmonary diseases, mainly aspergilloma, chronic necrotizing pulmonary aspergillosis (CNPA), and allergic bronchopulmonary aspergillosis (ABPA) in the underlying chronic lung diseases. [3, 4] Further, clinical studies about the detailed spectrum of aspergillosis in treated tuberculosis (TB) patients are lacking in India. A study was, therefore, undertaken at the Institute of Respiratory Diseases, SMS Medical College, Jaipur, Rajasthan, India.
Subjects and Methods
Old treated patients of pulmonary TB showing cavitary pulmonary lesion with paracavitary infiltrates or new cavity formation or expansion of cavity size over time or ball-like lesions inside the old cavities or a recent thickening of cavity wall were enrolled and subjected to further clinical assessment and laboratory investigations including complete blood count, blood sugar, urea, human immunodeficiency virus (HIV) serology, urine examination, sputum for Ziehl-Neelsen stain, BACTEC culture for Mycobacterium tuberculosis, fungal potassium hydroxide mount, and culture. Patients with evidence of active pulmonary TB, HIV, or clinicoradiological evidence of improvement on antibiotics were excluded from the study. Bronchoscopy was performed in two patients. Seventy patients whose sputum and/or bronchial wash showed isolation of Aspergillus were included in the study. Daniel criteria were used to diagnose aspergilloma and CNPA in residual cavitary lesions and Rosenberg-Patterson criteria were used to diagnose ABPA. [5, 6] 
Results
The intake of patients for the study started in July 2016 and was completed in December 2017. After exclusion, a total of 110 treated pulmonary TB patients who presented symptomatically with sputum smear negative were examined, out of which 70 (63.6%) were found to have aspergillosis, thus included in the study. The mean age of the study patients was 42.8 ± 17.2 years. Females outnumbered males by a ratio of 3:2. By occupation, 33 patients were farmer and 12 were laborer [ Table 1 ]. Hemoptysis (72.93%) of varying severity was the most common symptom, followed by wet cough (35.75%), chest pain (32.89%), weight loss (25.74%), dyspnea (20.02%), fever (20.02%), and dry cough (2.86%) [ Table 2 ]. Comorbidities such as anemia, asthma, diabetes mellitus, and hypertension were present in 50%, 12.83%, 7.10%, and 7.10% of patients, respectively, and no comorbidities were found in 22.88% of patients. The duration of illness was <1 year, 1-2 years, and >2 years in 27.17%, 52.91%, and 20.02% of patients, respectively [ Table 3 ]. Chest X-ray showed fibrocavitary disease (50%), aspergilloma (22.88%), bronchiectasis (20.02%), and patchy infiltrate (7.15%). Computed tomography (CT) scan was suggestive of aspergilloma in 72.88% of patients, fibrocavitary disease in 50% of patients, pleural thickening in 25.74% of patients, and bronchiectasis in 22.88% of patients [ Table 4 ]. Aspergillus fumigatus was the most common species isolated in 47 patients followed by Aspergillus terreus (9) , Aspergillus flavus (9), and Aspergillus niger (5) [ Table 5 ].
Aspergilloma was diagnosed in forty patients (57%) on the basis of Monad's sign and fungal culture. Thirty-five patients (36%) were diagnosed with CNPA on the basis of clinical, radiological, and microbiological criteria. aspergilloma. CNPA is diagnosed by chronic (>1 month) pulmonary or systemic symptoms including at least one of the following: weight loss, productive cough, hemoptysis with no overt immunocompromising conditions, and radiologically by cavitary pulmonary lesion with paracavitary infiltrates or new cavity formation or expansion of cavity size over time. [10] [11] [12] The microbiological criteria included isolation of Aspergillus species from pulmonary or pleural cavity or positive serum Aspergillus precipitin test. ABPA is diagnosed by Rosenberg-Patterson criteria which included a history of asthma and immediate cutaneous hyperreactivity to Aspergillus antigens or elevated specific serum IgE and elevated total IgE (>1000 IU/ml) and raised A. fumigates-specific IgG or presence of serum precipitins.
Although chest radiography is the initial examination of choice, in our study, it could show only 16 cases of aspergilloma. CT scan was found to be much more superior as it could pick 51 cases of aspergilloma out of the 70 patients. Furthermore, CT provided useful information regarding the extent of pulmonary disease and any associated pleural thickening.
A limitation of our study was that anti-Aspergillus antibody was not done in all suspected patients. If that could have been included, probably the number of aspergillosis patients in treated pulmonary TB would have been higher.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Only five patients (7%) had ABPA without peripheral eosinophilia [ Table 6 ].
Discussion
Aspergillus species are commonly found in every region of the world. Aspergillus species are commonly found in soil and decaying vegetation. They can be found in household dust, building materials, ornamental plants, flower arrangements, tobacco, food, and water. Conditions enhancing dispersal of molds are activities such as construction, demolition, excavation, disturbance of dust accumulations during routine cleaning, water leaks, and moisture accumulation. [7] Among them, twenty are pathogenic in humans. Aspergillus species release conidia at high concentrations (1-100 conidia/m 3 ) that are small enough (2-3 µm) to reach the pulmonary alveoli and cause a variety of pulmonary diseases. [8] The presentation of aspergillosis varies from aspergilloma, CNPA, to ABPA in treated pulmonary TB patients.
Aspergilloma is characterized by classical radiological Monad's sign and positive Aspergillus precipitin test or sputum culture positive for Aspergillus or both. [9] The demonstration of a mobile mass within a cavity on supine and prone scans is virtually diagnostic of 
